While PSP had the most differences with other tauopathies, a caveat to these results was the lower degree of tau aggregation in that PSP frontal cortex, making it appear more like control cases in Western blots and immunostaining of FFPE tissue. The gene discussed is MAPT; the disease is tauopathy.